Clinical Trials Logo

Clinical Trial Summary

A decreased sense of smell (hyposmia) is often caused by viral infections, such as COVID-19. Today, the only recommended treatment for hyposmia is olfactory training, a time consuming method with limitations in terms of both compliance and effect. The aim of this study is therefore to evaluate, as well as optimize, a new treatment method for olfactory loss. Hyposmic participants will be recruited and randomized into two different treatment conditions. One group will do regular olfactory training and the other will do passive olfactory training with scented nose plugs. The training will be conducted in the home of the individual monday through friday for two consecutive months. Subjective and objectvie measures of olfactory problems will be assessed before and after treatment, as well as subjective measures related to quality of live and genereal wellbeing.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06142565
Study type Interventional
Source Karolinska Institutet
Contact Johan N Lundström
Phone +46700913149
Email johan.lundstrom@ki.se
Status Recruiting
Phase N/A
Start date October 17, 2023
Completion date April 17, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06019000 - Study of CYR-064 Versus Placebo in Patients. Phase 2
Completed NCT05445921 - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Phase 1/Phase 2
Completed NCT04853836 - Olfactory Disfunction and Co-ultraPEALut Phase 4
Completed NCT05152030 - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting NCT05837637 - The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease
Recruiting NCT05384561 - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 N/A
Not yet recruiting NCT04661800 - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis N/A
Completed NCT04789499 - Smell in Covid-19 and Efficacy of Nasal Theophylline Phase 2
Recruiting NCT05364125 - Olfactory Training on Smell Dysfunction Patients in HK N/A
Completed NCT05461365 - Intranasal Insulin for COVID-19-related Smell Loss Phase 3
Completed NCT04710394 - Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell N/A
Completed NCT05184192 - Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Phase 2
Not yet recruiting NCT05421221 - Olfactory Training in COVID-19 Associated Loss of Smell N/A